Tufts University researchers have received a $20.7 million grant to lead the largest NIH-funded prospective study of patients with chronic Lyme disease to date, following patients from their earliest diagnosis to better identify why some people go on to develop debilitating symptoms later on.
Nutritional supplements offer a convenient way to easily increase your daily intake of vitamins, minerals, and other nutrients without making significant lifestyle changes.
In a game-changing study, Oak Ridge National Laboratory scientists developed a deep learning model — a type of artificial intelligence that mimics human brain function — to analyze high-speed videos of plasma plumes during a process called pulsed laser deposition, or PLD.
The Blavatnik Family Foundation and the New York Academy of Sciences have recognized chemical engineer Juan Jimenez as a Finalist in the 2024 Blavatnik Regional Awards for Young Scientists. Jimenez’s catalysis science research at the U.S. Department of Energy’s (DOE) Brookhaven National Laboratory opens doors for turning climate change-driving gases into industrially useful materials.
Machine learning algorithms significantly outperform human judgment in detecting lying during high-stakes strategic interactions, according to new research from the University of California San Diego’s Rady School of Management. The study can have major implications for the spread of misinformation, as machine learning could be used to bolster efforts to reduce fictitious content on major platforms like YouTube, Tik-Tok and Instagram.
Understanding and controlling heat flow is critical for many applications, especially for electronics. As these devices become smaller, the interfaces between materials often become the bottleneck to removing heat.
A new study from researchers at Wake Forest University School of Medicine shows that inpatient food insecurity, experienced by caregivers during their child’s hospitalization, is associated with not only longer hospital admissions but also significantly increased odds of readmission.
People with rare genetic variants associated with Parkinson’s disease and other neurodegenerative disorders are at increased risk of developing amyotrophic lateral sclerosis (ALS), according to new research presented at the 149th Annual Meeting of the American Neurological Association (ANA).
The study is the first to find that rare variants linked to other neurodegenerative diseases are associated with ALS, also known as Lou Gehrig’s disease. Researchers also found having these rare variants raises the risk of faster progression of ALS as well as shorter survival.
While colds and flu are detected year round in the U.S., the prevalence of both tends to increase in the fall and winter. Add in COVID-19, and you’ll see a lot of overlap. A Hackensack Meridian Health expert shares what you need to know to be ready for the season.
Starting patients with multiple sclerosis (MS) on aggressive treatment earlier may help prevent the development of paramagnetic rim lesions (PRL), areas of chronic brain inflammation that are linked to faster decline due to the disease, suggests new research presented at the 149th Annual Meeting of the American Neurological Association (ANA).
People with MS who have PRLs tend to have greater brain atrophy and disability. Treatment for MS includes low-, moderate- or high-efficacy disease-modifying therapies (DMTs), such as monoclonal antibodies, immunomodulators and immunosuppressants. While high-efficacy DMTs have more side effects, previous research suggests they may help prevent PRLs from forming (unlike low- or moderate-efficacy DMTs), potentially outweighing the downsides. No currently available DMT has been shown to reduce existing PRLs.
Over half of parents report at least one factor that makes it difficult for their child to make new friends, with about one in five saying that shyness or being socially awkward got in the way of their child’s efforts to make new friends.
The discovery of a new blood group, MAL, has solved a 50- year-old mystery. The findings allow identification and treatment of rare patients lacking this blood group.
Contrary to common perceptions and years of research that autistic people can’t describe their emotions or often have muted emotional responses, a Rutgers study published in the American Journal of Occupational Therapy concludes that many autistic adults are in fact acutely aware of their feelings and can label them in vivid, often colorful detail.
During the European Society for Medical Oncology (ESMO) Congress, Saby George, MD, FACP, of Roswell Park Comprehensive Cancer Center presented findings on a novel two-agent treatment that more than doubled progression-free survival compared with single-agent treatment.
Artificial intelligence (AI) is poised to revolutionize the care of neurological diseases, from detecting tumors the human eye can’t see and using implantable devices to manage various conditions to crunching data from thousands of people with the same condition to guide the development of new treatments, according to neurologists and biomedical researchers speaking at the Presidential Symposium – Present and Future Applications of AI in Neurological Care and Research at the 149th Annual Meeting of the American Neurological Association (ANA).